FDA Inspection 1176154 — China Resources Saike Pharmaceutical Co., Ltd.
The FDA completed an inspection of China Resources Saike Pharmaceutical Co., Ltd. on Jul 1, 2022 in Beijing. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 1, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beijing (China)